Shots: The approval is based on P-III ELLIPSE study results assessing Victoza (liraglutide, 1.8 mg/day) injection vs PBO + metformin with/without basal insulin in 135 children & adolescents in a […]readmore
Tags : Type-2
Shots: (NCT01243424) study results involve assessing of Tradjenta (5mg, qd) vs glimepiride in patients with type2 diabetes across 43 countries for 6+years The CAROLINA study resulted in meeting its 1EPs […]readmore
Shots: The two P-III PRONTO-T1D & PRONTO-T2D studies result involves assessing of Ultra Rapid Lispro (URLi) vs Humalog (insulin lispro), both in combination with insulin glargine/degludec in 1,222 & 673 […]readmore
Regulatory
AstraZeneca’s Qternmet XR (dapagliflozin, saxagliptin, metformin hydrochloride) Receives FDA’s Approval
Shots: The approval is based on two P-III studies assessing the combination of dapagliflozin (5mg, 10mg) ,saxagliptin (5mg) and metformin in patients with inadequately controlled Type-2 diabetes for 24wks. The […]readmore